Search
Descriptor English: Tripelennamine
Descriptor Spanish: Tripelenamina
Descriptor tripelenamina
Scope note: Antagonista de los receptores histamínicos H1 con poca acción sedante que, con frecuencia, causa irritación gastrointestinal. Se utiliza para el tratamiento del ASMA, FIEBRE DEL HENO, URTICARIA y RINITIS y también en aplicaciones veterinarias. La tripelenamina se administra por varias vías, incluyendo la administración tópica.
Descriptor Portuguese: Tripelenamina
Descriptor French: Tripélennamine
Entry term(s): Azaron
Histantin
Pyribenzamine
Tripelennamine Citrate
Tripelennamine Citrate (1:1)
Tripelennamine Hydrochloride
Tripelennamine Maleate
Tripelennamine Maleate (1:1)
Tripelennamine Monohydrochloride
Vetibenzamin
Tree number(s): D02.092.782.258.368.900
D03.383.725.050.920
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014309
Scope note: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Histamine H1 Antagonists
Anti-Allergic Agents
Registry Number: 3C5ORO99TY
CAS Type 1 Name: 1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-
DeCS ID: 14710
Unique ID: D014309
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2018/03/01
Tripelennamine - Preferred
Concept UI M0022012
Scope note A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Preferred term Tripelennamine
Vetibenzamin - Narrower
Concept UI M000638571
Preferred term Vetibenzamin
Azaron - Narrower
Concept UI M0476925
Preferred term Azaron
Tripelennamine Maleate (1:1) - Narrower
Concept UI M0329566
Preferred term Tripelennamine Maleate (1:1)
Pyribenzamine - Narrower
Concept UI M0351274
Preferred term Pyribenzamine
Tripelennamine Citrate - Narrower
Concept UI M0022013
Preferred term Tripelennamine Citrate
Entry term(s) Tripelennamine Citrate (1:1)
Tripelennamine Hydrochloride - Narrower
Concept UI M0329564
Preferred term Tripelennamine Hydrochloride
Tripelennamine Maleate - Narrower
Concept UI M0329565
Preferred term Tripelennamine Maleate
Tripelennamine Monohydrochloride - Narrower
Concept UI M0329563
Preferred term Tripelennamine Monohydrochloride
Histantin - Narrower
Concept UI M0551823
Preferred term Histantin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey